|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Reduced Dose Intensities of
Doxorubicin
in Elderly Patients with DLBCL in Rituximab Era
Hyerim Ha, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo
Cancer Res Treat.
2016;48(1):304-311. Published online April 9, 2015 DOI:
https://doi.org/10.4143/crt.2014.339
Web of Science 7
Crossref 8
A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin
Cancer Res Treat.
2010;42(4):235-238. Published online December 31, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.4.235
Crossref 14
Combination Chemotherapy with Etoposide,
Doxorubicin
, Cisplatin (EAP) for Recurred or Metastatic Gastric
Nam Kuk Cho, Tae Sik Choi, Yeon Hee Park, Seung Chul Lee, Young Jin Yuh, Sung Rok Kim
J Korean Cancer Assoc.
2000;32(3):524-530.
Isolation of Differentially-Displayed cDNAs from a Doxrubicin Resistant Gastric Carcinoma Cell Line
Myung Soo Kang, Jae Ho Lee, Jae Gahb Park
J Korean Cancer Assoc.
1998;30(4):625-631.
Phase 2 study of Ifosfamide Single and Ifosfamide and
Doxorubicin
Combination Chemotherapy for Hepatocellular Carcinoma
Soo Jeong Park, Hyeoung Joon Kim, Chul Won Jung, Sang Jae Lee
J Korean Cancer Assoc.
1996;28(4):718-726.
Alterations in DNA Cleavage Site of Topoisomerase 2 by Benzo(a)pyrene , m-AMSA , Ellipticine and
Doxorubicin
in Human c-myc Protooncogene
Sang Wook Lee, In Cheol Jeong, Moo Youn Cho
J Korean Cancer Assoc.
1996;28(3):520-533.
A Phase 2 Study on Combined 5 - Fluorouracil , Etoposide ,
Doxorubicin
and Cisplatin ( F - EAP ) in Patients with Advanced Gastric Cancer
J Korean Cancer Assoc.
1994;26(1):9-16.
1
Journal Impact Factor 4.6